Insider Transactions Reported by 15 Insiders of Metagenomi, Inc.

Symbol
MGX on Nasdaq
Location
Emeryville, CA

Insiders trading volume in the past year

Metagenomi, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BAYER HEALTHCARE LLC 10%+ Owner $11,666,871 13 Feb 2024
Sebastian Bernales Director $6,620,950 01 Apr 2024
Novo Holdings A/S 10%+ Owner $5,008,824 09 Feb 2024
Brian C. Thomas Director $4,449,170 -$30,549 -0.68% 05 Dec 2025
Jian Irish Chief Executive Officer, Director $999,066 -$16,921 -1.7% 05 Dec 2025
Simon Harnest Title: Chief Investment Officer and Senior Vice President of Strategy $353,272 01 Apr 2024
Pamela Wapnick Chief Financial Officer $334,811 -$11,793 -3.4% 05 Dec 2025
Simren Delaney Title: Vice President of Intellectual Property and Legal Operations $270,409 01 Apr 2024
Matthew Wein Title: General Counsel, Compliance Officer and Corporate Secretary $203,823 -$2,805 -1.4% 05 Dec 2025
Luis Borges Chief Scientific Officer $199,630 01 Apr 2024
Sarah B. Noonberg Chief Medical Officer $190,986 -$9,168 -4.6% 06 Jun 2025
Juergen Eckhardt Director 10 Jun 2025
Willard H. Dere Director 10 Jun 2025
ERIC BJERKHOLT Director 10 Jun 2025
Laurence Reid Director 02 Sep 2025

Recent Insider Transactions by Companies or Individuals for Metagenomi, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.